Global Immunodiagnostics Market

Immunodiagnostics Market Size, Share, Growth Analysis, By Product(Reagents & Kit (ELISA Reagents & Kit, CLIA Reagents & Kit, IFA Reagents & Kit, Rapid Test Reagent & Kit), By Technology(Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay), By Specimen(Blood, Saliva, Urine, Other), By Application(Infectious diseases, Endocrinology, Oncology, Bone & mineral Disorders), By End User(Hospitals & Clinics, Clinical laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Bank), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2401 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 66 |Figures: 75

Immunodiagnostics Market Insights

Immunodiagnostics Market size was valued at USD 16.2 billion in 2021 and is poised to grow from USD 17.44 billion in 2022 to USD 31.43 billion by 2030, at a CAGR of 7.64% during the forecast period (2023-2030).

The global immunodiagnostics market is experiencing significant growth driven by several factors. Immunodiagnostics refers to the use of immune system-based assays for the diagnosis and monitoring of various diseases.

The market is fueled by the increasing prevalence of infectious diseases, autoimmune disorders, and cancer, creating a demand for accurate and efficient diagnostic tools.

Technological advancements in immunoassay platforms, such as enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), and rapid diagnostic tests, have improved sensitivity and specificity, contributing to market growth.

Additionally, the rising awareness about early disease detection and the benefits of personalized medicine have further propelled the demand for immunodiagnostics.

US Immunodiagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2023-2030

Global Market Size

USD 16.2 billion

Largest Segment

reagent and kits

Fastest Growth

Growth Rate

7.64% CAGR

Global Immunodiagnostics Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Immunodiagnostics Market Segmental Analysis

Global Immunodiagnostics Market is segmented By Product, By Technology, By Specimen, By Application, By End User and By Region. Based on Product, the market can be segmented in to Reagents & Kit (ELISA Reagents & Kit, CLIA Reagents & Kit, IFA Reagents & Kit, Rapid Test Reagent & Kit, Western Blot Reagents & Kit, Other), Instruments, Software & Services. Based on Technology, the market can be segmented in to Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, ELISpot, Western Blotting and Others. Based on Specimen, the market can be segmented in to Blood, Saliva, Urine, Other. Based on Application, the market can be segmented in to Infectious diseases, Endocrinology, Oncology, Bone & mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergic Diagnostics, Toxicology, Newborn Screening and Other. Based on End User, the market can be segmented in to Hospitals & Clinics, Clinical laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Bank, Research & Academic Laboratories, Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Immunodiagnostics Market Analysis By Type

Among the segments in the global immunodiagnostics market, the largest segment is reagents & kits, while the fastest-growing segment is software & services. Reagents & kits hold the largest share in the market due to their crucial role in diagnostic testing. Additionally, advancements in reagent formulations, such as enhanced sensitivity and specificity, have further contributed to the segment's dominance. With the continuous development of novel reagents and kits, this segment is expected to maintain its leading position in the immunodiagnostics market.

On the other hand, the software & services segment is the fastest-growing segment in the market. This can be attributed to the rising adoption of digital solutions and the integration of software platforms in immunodiagnostics. The software & services segment is anticipated to witness substantial growth, driven by the need for efficient data management, workflow optimization, and improved patient care.

Immunodiagnostics Market Analysis By Application

Among the segments in the global immunodiagnostics market, the largest segment is infectious diseases, while the fastest-growing segment is oncology. The infectious diseases segment holds the largest share in the market due to the high prevalence of infectious conditions worldwide. With the increasing incidence of infectious diseases, the demand for immunodiagnostic tests has surged, driving the growth of this segment.

On the other hand, the oncology segment is the fastest-growing segment in the market. The field of oncology heavily relies on immunodiagnostics for cancer screening, diagnosis, prognosis, and monitoring treatment response. As a result, the oncology segment is expected to witness significant growth in the coming years.

Global Immunodiagnostics Market By type , 2021 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Immunodiagnostics Market Regional Insights

The global immunodiagnostics market exhibits regional variations, with certain regions dominating the market and others experiencing rapid growth. North America is the dominating region in the global immunodiagnostics market. The region's strong market position can be attributed to advanced healthcare infrastructure, extensive research and development activities, and favorable reimbursement policies. The presence of key market players and academic institutions actively involved in immunodiagnostics research further contributes to North America's dominance. For instance, in the United States, companies like Abbott Laboratories and Thermo Fisher Scientific are leading contributors to the immunodiagnostics market. The region's well-established healthcare system and early adoption of innovative technologies drive the demand for immunodiagnostics products and services, positioning North America as the leading market in the global landscape.

Asia-Pacific is the fastest growing region in the global immunodiagnostics market. The region's rapid growth is driven by several factors, including rising prevalence of chronic and infectious diseases, the increasing healthcare expenditure and growing awareness about early disease detection. Countries such as China, India, and Japan are witnessing significant market growth due to their large population base and growing healthcare infrastructure. For instance, China has witnessed a surge in demand for immunodiagnostics amid the COVID-19 pandemic, with companies like F. Hoffmann-La Roche Ltd and Siemens Healthineers playing a key role in the market. Additionally, the rising focus on personalized medicine and advancements in healthcare technology contribute to the growth of the immunodiagnostics market in Asia-Pacific.

Global Immunodiagnostics Market By Geography, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Immunodiagnostics Market Dynamics

Immunodiagnostics Market Drivers

Growing Emphasis on Early Disease Detection

  • There is a growing focus on early disease detection to improve treatment outcomes and reduce healthcare costs. Immunodiagnostics enable the detection of specific biomarkers and molecular targets, facilitating early diagnosis and personalized treatment approaches based on individual patient characteristics.

Immunodiagnostics Market Restraints

High Cost of Immunodiagnostics

  • The high cost associated with immunodiagnostics, including the purchase of equipment, reagents, and maintenance, can limit the adoption of these tests, especially in resource-limited settings. The cost factor poses a challenge for widespread implementation of immunodiagnostics, particularly in developing regions.

Request Free Customization of this report to help us to meet your business objectives.

Immunodiagnostics Market Competitive Landscape

The competitive landscape of the global immunodiagnostics market is characterized by intense competition among key players striving to maintain their market positions and gain a competitive edge. These companies focus on strategies such as mergers and acquisitions, collaborations, product launches, and partnerships to expand their product portfolios, enhance their market presence, and cater to the evolving needs of healthcare providers and patients.

Immunodiagnostics Market Top Player’s Company Profiles

  • Abbott Laboratories (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Siemens Healthineers (Germany)
  • Thermo Fisher Scientific Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Danaher Corporation (United States)
  • DiaSorin S.p.A. (Italy)
  • Ortho Clinical Diagnostics (United States)
  • QIAGEN N.V. (Netherlands)
  • Becton, Dickinson and Company (United States)
  • bioMérieux SA (France)
  • PerkinElmer, Inc. (United States)
  • Sysmex Corporation (Japan)
  • Merck KGaA (Germany)
  • Mindray Medical International Limited (China)
  • Luminex Corporation (United States)
  • Agilent Technologies, Inc. (United States)
  • Hologic, Inc. (United States)
  • Grifols, S.A. (Spain)
  • Randox Laboratories Ltd. (United Kingdom)

Immunodiagnostics Market Recent Developments

  • In July 2022, Abbott Diagnostics made an announcement regarding its participation in the American Association for Clinical Chemistry (AACC) 2022 event. During the exhibition, the company showcased its range of diagnostic systems and analyzers.

Immunodiagnostics Key Market Trends

  • One key market trend that has been observed in recent years is the increasing adoption of digital health solutions. The advancement of technology, coupled with the growing need for efficient and accessible healthcare, has led to the integration of digital tools and services in the healthcare industry. Digital health solutions encompass a wide range of technologies, including telemedicine, mobile health applications, wearable devices, and remote patient monitoring systems. These innovations have revolutionized healthcare delivery by enabling remote consultations, personalized health monitoring, and real-time data sharing between patients and healthcare providers.

Immunodiagnostics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Deployment mode team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, the global immunodiagnostics market is poised for robust growth in the foreseeable future. The adoption of digital health solutions has the potential to improve patient outcomes, enhance access to care, and optimize healthcare resources. Moreover, it has opened up new opportunities for healthcare providers, tech companies, and investors to collaborate and innovate in order to meet the evolving needs of the healthcare industry. As the demand for more efficient and patient-centric healthcare continues to rise, the market trend of digital health is expected to further expand and shape the future of healthcare delivery.

Report Metric Details
Market size value in 2021 USD 16.2 billion
Market size value in 2030 USD 31.43 billion
Growth Rate 7.64%
Base year 2023
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Reagents & Kit (ELISA Reagents & Kit, CLIA Reagents & Kit, IFA Reagents & Kit, Rapid Test Reagent & Kit, Western Blot Reagents & Kit, Other), Instruments, Software & Services
  • Technology
    • Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, ELISpot, Western Blotting and Others
  • Specimen
    • Blood, Saliva, Urine, Other
  • Application
    • Infectious diseases, Endocrinology, Oncology, Bone & mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergic Diagnostics, Toxicology, Newborn Screening and Other
  • End User
    • Hospitals & Clinics, Clinical laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Bank, Research & Academic Laboratories, Home Care Settings
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Siemens Healthineers (Germany)
  • Thermo Fisher Scientific Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Danaher Corporation (United States)
  • DiaSorin S.p.A. (Italy)
  • Ortho Clinical Diagnostics (United States)
  • QIAGEN N.V. (Netherlands)
  • Becton, Dickinson and Company (United States)
  • bioMérieux SA (France)
  • PerkinElmer, Inc. (United States)
  • Sysmex Corporation (Japan)
  • Merck KGaA (Germany)
  • Mindray Medical International Limited (China)
  • Luminex Corporation (United States)
  • Agilent Technologies, Inc. (United States)
  • Hologic, Inc. (United States)
  • Grifols, S.A. (Spain)
  • Randox Laboratories Ltd. (United Kingdom)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Immunodiagnostics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Immunodiagnostics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Immunodiagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunodiagnostics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunodiagnostics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Immunodiagnostics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Immunodiagnostics Market size was valued at USD 16.2 billion in 2021 and is poised to grow from USD 17.44 billion in 2022 to USD 31.43 billion by 2030, at a CAGR of 7.64% during the forecast period (2023-2030).

The competitive landscape of the global immunodiagnostics market is characterized by intense competition among key players striving to maintain their market positions and gain a competitive edge. These companies focus on strategies such as mergers and acquisitions, collaborations, product launches, and partnerships to expand their product portfolios, enhance their market presence, and cater to the evolving needs of healthcare providers and patients. 'Abbott Laboratories (United States)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'Siemens Healthineers (Germany)', 'Thermo Fisher Scientific Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'Danaher Corporation (United States)', 'DiaSorin S.p.A. (Italy)', 'Ortho Clinical Diagnostics (United States)', 'QIAGEN N.V. (Netherlands)', 'Becton, Dickinson and Company (United States)', 'bioMérieux SA (France)', 'PerkinElmer, Inc. (United States)', 'Sysmex Corporation (Japan)', 'Merck KGaA (Germany)', 'Mindray Medical International Limited (China)', 'Luminex Corporation (United States)', 'Agilent Technologies, Inc. (United States)', 'Hologic, Inc. (United States)', 'Grifols, S.A. (Spain)', 'Randox Laboratories Ltd. (United Kingdom)'

There is a growing focus on early disease detection to improve treatment outcomes and reduce healthcare costs. Immunodiagnostics enable the detection of specific biomarkers and molecular targets, facilitating early diagnosis and personalized treatment approaches based on individual patient characteristics.

One key market trend that has been observed in recent years is the increasing adoption of digital health solutions. The advancement of technology, coupled with the growing need for efficient and accessible healthcare, has led to the integration of digital tools and services in the healthcare industry. Digital health solutions encompass a wide range of technologies, including telemedicine, mobile health applications, wearable devices, and remote patient monitoring systems. These innovations have revolutionized healthcare delivery by enabling remote consultations, personalized health monitoring, and real-time data sharing between patients and healthcare providers.

The global immunodiagnostics market exhibits regional variations, with certain regions dominating the market and others experiencing rapid growth. North America is the dominating region in the global immunodiagnostics market. The region's strong market position can be attributed to advanced healthcare infrastructure, extensive research and development activities, and favorable reimbursement policies. The presence of key market players and academic institutions actively involved in immunodiagnostics research further contributes to North America's dominance. For instance, in the United States, companies like Abbott Laboratories and Thermo Fisher Scientific are leading contributors to the immunodiagnostics market. The region's well-established healthcare system and early adoption of innovative technologies drive the demand for immunodiagnostics products and services, positioning North America as the leading market in the global landscape.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Immunodiagnostics Market

Product ID: SQMIG35A2401

$5,300
BUY NOW GET FREE SAMPLE